Ngiyabonga ngokuvakashela imvelo.com. Uhlobo lwesiphequluli osisebenzisayo lunokusekelwa kwe-CSS okukhawulelwe. Ngomuzwa omuhle kakhulu, sincoma ukuthi usebenzise isiphequluli esibuyekeziwe (noma khubaza imodi yokuhambisana ne-Internet Explorer). Okwamanje, ukuqinisekisa ukusekelwa okuqhubekayo, sizonikela ngesiza ngaphandle kwezitayela kanye ne-javascript.
Ama-peptides namaprotheni asetshenziswa kabanzi ukwelapha izifo ezahlukahlukene, kepha imvamisa kufanele ananyene futhi umphumela wazo uhlala isikhashana. Lokhu kushiyeka kwezinhlaka zomdabu kungaqedwa ngosizo lobunjiniyela be-molecular, kepha lo msebenzi onzima. Amasu wobunjiniyela amamolekyuli, ekuqaleni asetshenziswa ku-insulin futhi manje asetshenziswe ngempumelelo kuma-biopharmaceuticals ambalwa, adinga ukusulwa kwama-peptides namaprotheni avela kuma-fatty acids. Izici ezithile nendawo yama-acid anamathiselwe anganikeza izindlela ezahlukahlukene zokubumbana. Ngaphezu kwalokho, lobu buchwepheshe bunganikeza impilo ende yokuphila ngemuva kokuphathwa komlomo kwezidakamizwa ze-peptide, kungaguqula ukusatshalaliswa kwama-peptides, futhi kungahle kube namandla okuqondiswa kwezicubu. Ngokuphepha okungokwemvelo kwama-acid anamafutha kanye nezakhiwo zamakhemikhali ezichazwe kahle, lobu buchwepheshe buhlinzeka ngendlela eguquguqukayo ekutholeni izidakamizwa kanye nokutholwa kwezidakamizwa.
Wonke amanani anetha. I-VAT izongezwa ngokuhamba kwesikhathi ekuphumeni. Izibalo zentela zizokwenziwa lapho kuphuma khona.
Muttenthaler, M., King, Gf, Adams, DJ & Alewood, PF Trends ekutholeni izidakamizwa. Muttenthaler, M., King, Gf, Adams, DJ & Alewood, PF Trends ekutholeni izidakamizwa.Muttenthaler, M., King, Gf, Adams, DJ no-Alevad, TF TRENDS ekutholeni izidakamizwa. Muttenthaler, M., King, Gf, Adams, DJ & Alewood, Pf 多肽药物发现的趋势. Muttenthaler, M., King, Gf, Adams, Dj & Alewood, PFMuttenthaler, M., King, Gf, Adams, DJ no-Alevad, TF TRENDS ekutholeni izidakamizwa.Kuzwelonke ukuvulwa komfundisi wezidakamizwa. 20, 309-325 (2021). Lokhu kubuyekezwa kugxile ezicini zamanje nezesikhathi esizayo zokutholwa kwezidakamizwa ze-peptide.
UMüller, TD, Blüher, M., TSCHöp, MH & Dimarchi, Rd Anti-Ofesity Discovery: Intuthuko Nezinselelo. UMüller, TD, Blüher, M., TSCHöp, MH & Dimarchi, Rd Anti-Ofesity Discovery: Intuthuko Nezinselelo.UMüller, i-TD, uBlucher, uM. UMüller, TD, BLüher, M., TSchöp, MH & Dimarchi, Rd 抗肥胖药物发现: 进展和挑战. UMüller, TD, BLüher, M., TSchöp, MH & Dimarchi, RdUMüller, i-TD, uBlucher, uM.Kuzwelonke ukuvulwa komfundisi wezidakamizwa. 21, 201-223 (2022). Lokhu kubuyekezwa kuhlinzeka ngokuqonda ezinkingeni zokukhuluphala, ikakhulukazi imiqondo emisha esekelwe kuma-peptides.
I-Strohl, amaprotheni e-WRUBSION ahlanganisiwe ukwelula i-Half-Life of Biologics njengecebo elihle kakhulu le-Biologics. I-Biopharmaceutics 29, 215-239 (2015).
U-Evans, uM. Et al. Ukubambelela nokuphikelela kwemithi ye-antidialetic kanye nobudlelwano nemiphumela yezomtholampilo nezomnotho ezigulini ezinesifo sikashukela sohlobo 2: Ukubuyekezwa okuhleliwe kwezincwadi. Ukukhuluphala kwesifo sikashukela. metabolism. 24, 377-390 (2022).
Polonsky, wh, fisher, L., Hessler, D., Bruhn, D. & Best, JH Imibono ngemithi wake wangena masonto onke wesifo sikashukela. Polonsky, wh, fisher, L., Hessler, D., Bruhn, D. & Best, JH Imibono ngemithi wake wangena masonto onke wesifo sikashukela.Polonsky wh, fisher l. Polonsky, wh, fisher, L., Hessler, D., Bruhn, D. & Best, JH 患者对每周一次的糖尿病药物的看法. Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JHPolonsky wh, fisher l.Ukukhuluphala kwesifo sikashukela. metabolism. 13, 144-149 (2011).
UHashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. Synthesis of Palemittoyl Depivatives of insulin nemisebenzi yabo yemvelo. UHashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. Synthesis of Palemittoyl Depivatives of insulin nemisebenzi yabo yemvelo.UHashimoto M., Takada K., Kiso y. noMuranishi S. S. Swap of Palemittoyl Derivatives of insulin kanye nomsebenzi wabo wezinto eziphilayo. I-Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. 胰岛素棕榈酰衍生物的合成及其生物活性. I-Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. Synthesis kanye nomsebenzi wezinto eziphilayo ze-insulin palmittoyl derivatives.IHashimoto M., Takada K., Kiso Y. noMuranishi S. S.I-Medicine Reservoir 6, 171-176 (1989).
Kurtzhals, P. et al. I-Albemin ibopha i-insulin enamafutha acid-acylited I-Biochem. J. 312, 725-731 (1995). Lo msebenzi ungowokuqala ukukhombisa ukwanda kwempilo-impilo ngenxa yokubopha i-albhamuin kuma-poptides athathwe kuma-fatty acids.
I-Mejuch, T. & Waldmann, H. Synthesis yamaprotheni ama-lipidated. I-Mejuch, T. & Waldmann, H. Synthesis yamaprotheni ama-lipidated.UMeyukh, uT. NoWaldmann, H. Synthesis wamaprotheni ahlanganisiwe. I-Mejuch, T. & Waldmann, H. 脂化蛋白质的合成. Mejuch, t. & Waldmann, h.UMeyukh, uT. NoWaldmann, H. Synthesis wamaprotheni ahlanganisiwe.Bioconjugate. Amakhemikhali. 27, 1771-1783 (2016).
Chen, B., ILanga, y., NIU, Jar, Jarugumilli, GK & WU, X. I-Protein Lipidation ekusayineni kweseli nezifo: Umsebenzi, umthetho, kanye namathuba okulawulwa. Chen, B., ILanga, y., NIU, Jar, Jarugumilli, GK & WU, X. I-Protein Lipidation ekusayineni kweseli nezifo: Umsebenzi, umthetho, kanye namathuba okulawulwa.UChen B., iSun Y., NIU J., Jarugumilli GK ne-WU X. I-Protein Lipidation ku-Cell Sipidaling kanye nezifo: Umsebenzi, umthetho, kanye ne-Therapeutic, kanye ne-Therapeutic amandla. Chen, B., ILanga, Y., NIU, Jar, Jarugumilli, GK & WU, GK & WU, GK & WU, GK & WU, GK & WU, GK & WU, GK & WU, GK. Chen, B., ILanga, y., NIU, Jar, Jarugumilli, GK & WU, X. ProteinUChen B., iSun Y., NIU J., Jarugumilli GK ne-WU X. I-Protein Lipidation ku-Cell Sipidaling kanye nezifo: Umsebenzi, umthetho, kanye ne-Therapeutic, kanye ne-Therapeutic amandla.cytochemistry. I-Biology 25, 817-831 (2018).
I-Richter, i-WF, Bhansali, SG & Morris izinqumo ze-biotherapeapeutics amunculispring elandelayo aphathe ukuphathwa kwe-SC. I-Richter, i-WF, Bhansali, SG & Morris izinqumo ze-biotherapeapeutics amunculispring elandelayo aphathe ukuphathwa kwe-SC.I-Richter, VF, Bhansali, SG neMorris, Me Mechaniss enquma ukumuncwa kwama-biotherapeapeutic agents ngemuva kokuphathwa kwe-subcutaneoutive. Richter, WF, Bhansali, SG & Morris, Me SC 给药后生物治疗药物吸收的机制决定因素. Richter, WF, Bhansali, Sg & Morris, Me SC I-WF, Bhansali, SG & Morris, Me SCехаех Пиоте Пех бихе Пр I-Richter, i-WF, Bhansali, SG & Morris, Me Mechanic Ukunqunywa kokutholwa kwezidakamizwa ze-biotherapeapeutic ngemuva kokuphathwa.I-Aaps J. 14, 559-570 (2012).
I-gratul, akj et al. Izici ezithinta ukumuncwa kwe-insulin ezingaphansi kwe-insulin: Imiphumela yokuhlukahluka. UJ. Isifo sikashukela res. 2018, 1205121 (2018).
I-Hildebrandt, P., Sejrsen, P., NIELSEn, SL, BIRCHUNT, L. POSTOFT, L. POLYMERIZAZINI, I-Hildebrandt, P., Sejrsen, P., NIELSEn, SL, BIRCHUNT, L. POSTOFT, L. POLYMERIZAZINI, I-Hildebrandt, P., Sejrsen, P., Nielsen, Sl, Birch, K. & STETOFT, L. д и ибуужна и Isikhalazo. I-Hildebrandt, P., Sejrsen, P., NIELSEn, SL, BIRCHUNT, L. POSTOFT, L. POLYMERIZAZWE, UHildebrandt, P., Sejrsen, P., Nielsen, Sl, Birch, K. & STETOFT, L. 扩散和聚合决定了糖尿病患者皮下组织对胰岛素的吸收. I-Hildebrandt, P., Sejrsen, P., Nielsen, Sl, Birch, K. & Sesteft, L. I-Hildebrandt, P., Sejrsen, P., Nielnen, Sl, Birch, K. & STETOFT, L. д и и огрега. с диабетоом. I-Hildebrandt, P., Sejrsen, P., NIELSEn, SL, Birch, K. & Stestoft, l. Ukuhlakulela ukunquma ukumuncwa kwe-insulin okungekho emthethweni kuziguli ezinesifo sikashukela.Ukuskena. J. Klin. elebhu. Tshala imali. 45, 685-690 (1985).
UMosekilde, E., Jensen, KS, I-Binder, C., Praming, S. & Thorsteinsson, B. Modeling Absorption Kinetics of injeka injeva efakwe inxusa. UMosekilde, E., Jensen, KS, I-Binder, C., Praming, S. & Thorsteinsson, B. Modeling Absorption Kinetics of injeka injeva efakwe inxusa.UMosen E, Jensen KS, i-Binder S, noThorsteinsson B. Modeling the Amunction Kinetics of Subcutaneous insulin invula engenamkhawulo. UMosekilde, E., Jensen, KS, I-Binder, C., Praming, S. & Thorsteinson, B. 模拟皮下注射可溶性胰岛素的吸收动力学. UMosekilde, E., Jensen, KS, Binder, C., Praming, S. & Thorsteinson, B.UMoseklde E, JENSEN KS, i-Bindering S, noThorsteinsson B. Modeling the Amuncurption Kinetics of insulin encibilikezwayo ephethwe ngokusobala.J. Pharmacokinetics. i-biopharmacy. 17, 67-87 (1989).
Kuna, M., Mahdi, F., CHADE, CHADE, GL III Molecular usayizi Molemacoketes ama-pharmacokinetics, ukubulaliseka kolwazi, kanye nokufakwa kabusha kwe-renal kokulethwa kwezidakamizwa kwe-biopolymer elastin-efana ne-polypEplepy enjenge-polypEpler e-elastin-efana. Kuna, M., Mahdi, F., CHADE, CHADE, GL III Molecular usayizi Molemacoketes ama-pharmacokinetics, ukubulaliseka kolwazi, kanye nokufakwa kabusha kwe-renal kokulethwa kwezidakamizwa kwe-biopolymer elastin-efana ne-polypEplepy enjenge-polypEpler e-elastin-efana. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III розерококококококококококококококококококококококококококококококококококококококону ,е даквббп дривк секоставого дледставогого Kuna, M., Mahdi, F., CHADE, CHADE, GL III Molecular usayizi Moleculates Pharmacokinetics, ukubulaliseka kolwazi, kanye nokubekwa kabusha kwe-biopolymeric elastin-efana ne-polypeptide yokulethwa kwezidakamizwa. Kuna, M., Mahdi, F., CHADE, AR & BIDwell, GL III 分子大小调节药物递送生物聚合物弹性蛋白样多肽的药代动力学, 生物分布和肾脏沉积. Kuna, M., Mahdi, F., Chade, AR & BIDwell, GL III Molecule 大小名行电影送送 I-Biological Polymer Elastic Protein Protein Isampula, Isahlulelo sebhayoloji 和鈥脏气度.Kuna, M., Mahdi, F., CHAD, AR kanye neBidwell, GL III. I-Pharmacokinetics, ukubikezelwa kokubikezelwa kokwenza izinto ezibonakalayo kanye ne-renal ye-biopolymeric elastin-like polypepdes ukuguqula usayizi we-molecule.Isayensi ibika 8, 7923 (2018).
UHarris, Jm, uMartin, Ne & Modi, M. Pegylation: Inqubo yenoveli yokushintsha amakhemisi. UHarris, Jm, uMartin, Ne & Modi, M. Pegylation: Inqubo yenoveli yokushintsha amakhemisi. Harris, Jm, Martin, Ne & Modi, M. Пегилкикин. UHarris, Jm, uMartin, Ne & Modi, M. Pegylation: Inqubo yenoveli yokushintsha amakhemisi. Harris, JM, Martin, Ne & Modi, M. 聚乙二醇化: 一种改变药代动力学的新方法. UHarris, JM, uMartin, Ne & Modi, M. 聚乙二感化: indlela entsha yokushintsha umuthi. Harris, Jm, Martin, Ne & Modi, M. Пегилин повынгод К п поы UHarris, JM, uMartin, Ne & Modi, M. Pegylation: Indlela entsha yokushintsha ama-Pharmacokinetics.Clinical. Ikhemisi. 40, 539-551 (2001).
U-Elmerer, uM. Et al. Ukukalwa kwe-albhamuin arststitic emsipha wamathambo womuntu kanye nezicubu ze-adipose nge-open flow micperfusion. Yebo. J. Physiology. I-Endocrine. metabolism. 278, e352-E356 (2000).
UNelson, J. et al. I-half-life ende ye-albhamuin ebantwini idinga i-C-terminus. ukuxhumana. Biology. 3, 181 (2020).
Chowdhury, K. et al. I-FC Receptor (FCRN) ye-IGG ehambisana ne-mast histocomtic J. EXP. umuthi. 197, 315-322 (2003).
U-Ober, RJ, uMartinez, C., Lai, X., Zhou, J. & EXOCYTOSIS, i-EXCYTOSIS ye-IGG njengoba kulawulwa yi-receptor, U-Ober, RJ, uMartinez, C., Lai, X., Zhou, J. & EXOCYTOSIS, i-EXCYTOSIS ye-IGG njengoba kulawulwa yi-receptor, Ober, RJ, Martinez, C., Lai, X., Zhou, J. & J. & JCRN на уд CCRN: U-Ober, RJ, uMartinez, C., Lai, X., Zhou, J. & JCRY REDET IGG Execytosis: Ukuhlaziywa kwe-molecule eyodwa. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Igg, FCRN: 单分子水平的分析. U-Ober, RJ, MARTINEZ, C., Lai, X., Zhou, J. & GALITE, ES Ober, RJ, Martinez, C., Lai, X., Zhou, J. & JCRN: резедованный резед U-Ober, RJ, uMartinez, C., Lai, X., Zhou, J. & Igg Execytosis, FCRN: I-MOLECROR-MELECULELE-LANGELE-ANGES-ANGELY-LANGEL.inqubo. I-National Academy of Science. Isayensi. I-US 101, 11076 (2004).
Yena, xm & Carter, isakhiwo se-atomic ye-DC kanye ne-chemistry ye-albhamuin yomuntu. Yena, xm & Carter, isakhiwo se-atomic ye-DC kanye ne-chemistry ye-albhamuin yomuntu.Ku-xm kanye ne-carter, isakhiwo se-atomic ye-DC kanye ne-chemistry ye-albhamuin yomuntu. Yena, xm & Carter, DC 人血清白蛋白的原子结构和化学. Yena, xm & Carter, DC.Ku-xm kanye ne-carter, isakhiwo se-atomic ye-DC kanye ne-chemistry ye-albhamuin yomuntu.Imvelo 358, 209-215 (1992).
I-Curry, S. Mandelkow, uH. I-Curry, S. Mandelkow, uH.I-Curry S., iMandelkow H., uBrick P. noFranks N. Ukwakheka kwe-crystal ye-albhamun yomuntu e-abuntu endabeni ye-acid enamafutha kukhombisa ukusatshalaliswa kwe-asymmetric kwamasayithi abophayo. I-Curry, S., Mandelkow, H., Brick, P. & Franks, N. 与脂肪酸复合的人血清白蛋白的晶体结构揭示了结合位点的不对称分布. I-Curry, S. Mandelkow, uH.I-Curry S., iMandelkow H., uBrick P. noFranks N. Ukwakheka kwe-crystal ye-albhamun yomuntu e-aucumin yabantu ku-acid acid kukhombisa ukusatshalaliswa kwe-asymmetric kwamasayithi abophayo.NAT. isakhiwo. I-Biology 5, 827-835 (1998). Leli phepha liveza isisekelo sesakhiwo sokubopha ama-acid anamafutha ku-Serum Albumin.
U-Irby, D., DU, C. & LI, F. I-Lipid-Drug Comnjugate yokuthuthukisa ukulethwa kwezidakamizwa. U-Irby, D., DU, C. & LI, F. I-Lipid-Drug Comnjugate yokuthuthukisa ukulethwa kwezidakamizwa.U-Irby, D., Du, K. noLi, F. Conjugates, F. I-Lipid-Drug Congnjugates yokulethwa kwezidakamizwa okuthuthukile. U-Irby, D., DU, C. & LI, F. I-Lipid-Drug Comnjugate yokuthuthukisa ukulethwa kwezidakamizwa. U-Irby, D., DU, C. & LI, F. I-Lipid-Drug Comnjugate yokuthuthukisa ukulethwa kwezidakamizwa.U-Irby, D., Du, K. noLi, F. I-Lipid-Drug Comnjugate yokulethwa kwezidakamizwa okuthuthukile.I-Biochemistry 14, 1325-1338 (2017).
I-Tortulin VP yakamuva intuthuko emkhakheni wama-liposomes njengezithwalweni zezidakamizwa. Kuzwelonke ukuvulwa komfundisi wezidakamizwa. 4, 145-160 (2005).
U-Bhat, uM., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. Amathuba nezinselelo zezimali ezihlanganisiwe zokwelapha. U-Bhat, uM., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. Amathuba nezinselelo zezimali ezihlanganisiwe zokwelapha.U-Bhat, uM., Jatyan, R., Mittal, A., Mahato, RI kanye neChitkara, D. Amathuba nezinselelo zezimali ezihlanganisiwe zokwelapha. I-Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. 脂肪酸共轭疗法的机遇和挑战. I-Bhat, uM., Jatyan, R., Mittal, A., Mahato, Ri & Chitkara, D. Fatty Acid Acid 共续电影的机遇和 Inselelo.I-Bhat M., JATYAn R., Mittal A., Mahato RI kanye neChitkara D. Amathuba nezinselelo zokwelashwa kwe-fatty acid conjugation.Amakhemikhali. I-Physics Lipids 236, 105053 (2021).
USmith, uR. & Tanford, C. Hydrophobicity of Long Chain N-ALKYL Carboxylic Acid, njengoba kulinganiswa ngokusatshalaliswa kwawo phakathi kwezixazululo ze-heptane nezamanziko. USmith, uR. & Tanford, C. Hydrophobicity of Long Chain N-ALKYL Carboxylic Acid, njengoba kulinganiswa ngokusatshalaliswa kwawo phakathi kwezixazululo ze-heptane nezamanziko.USmith, uR. NoTanford, K. Hydrophobicity wama-N-ALKYLLCARBEXYLY AID alinganiswa ngokusatshalaliswa kwawo phakathi kwezixazululo ze-heptane nezamanziko. USmith, R. & Tanford, C. 长链正烷基羧酸的疏水性, 通过它们在庚烷和水溶液之间的分布来测量. USmith, R. & Tanford, C. I-Hydrophobicity of 长链正 alkylcArboxylate, olinganiswa ngokusatshalaliswa kwawo phakathi kwe-hydrogen peroxide kanye nesisombululo esinamanzi.USmith, uR. NoTanford, K. Hydrophobicity wama-N-ALKYLLCARBEXYLY AID alinganiswa ngokusatshalaliswa kwawo phakathi kwezixazululo ze-heptane nezamanziko.inqubo. I-National Academy of Science. Science US 70, 289 (1973).
ULiu, J. et al. Ukutholwa okwenziwa masonto onke kwe-anaglutide analog ye-glucagon-efana ne-peptide-1 (glp-1). J. Medicine. Amakhemikhali. 58, 7370-7380 (2015). Lo msebenzi ukhombisa okokuqala ukuthi kungenzeka yini ukusebenzisa kanye ngeviki izindlela zokufunwa kwamafutha acid acid.
Østersgaard, S. et al. Umphumela we-Pyy3-36 dibasic fatty acid acylication emcimbini we-mini-pig y2 receptor kanye nengxenye yempilo. Isayensi. Bika 11, 21179 (2021). Lo mbhalo ukhombisa ukubaluleka kokuphakanyiswa kwe-acid, i-linker kanye nokuqina kwesikebhe ekuthuthukisweni kwama-analogi e-Pyy ende.
Isennat-vaser, R. et al. Ukungena kwama-pepretides amisiwe kulo lonke ulwelwesi lweseli kubhekwe ngqo kusetshenziswa i-microscopy ye-fluorescence evumayo. I-Iubmb Life 54, 33-36 (2002).
Nelson, AR, Borland, L., Allbritton, NL & Sims, CE Ukuhanjiswa okusekwe esekwe kumangqamuzana aphilayo kumaseli aphilayo. Nelson, AR, Borland, L., Allbritton, NL & Sims, CE Ukuhanjiswa okusekwe esekwe kumangqamuzana aphilayo kumaseli aphilayo.Nelson AR, Borland L, Allbritton NL. Futhi ama-Sims Se Peptide Transport emangqamuzane aphilayo asuselwa ku-MyRistoyl. Nelson, AR, Borland, L., Allbritton, NL & Sims, CE 基于肉豆蔻酰的肽转运到活细胞中. Nelson, AR, Borland, L., Allbritton, NL & Sims, CE.Nelson, AR, Borland, L., Albritton, NL. Futhi ama-sims, u-ke ezokuthutha ama-meptides asuselwa ku-myristoyl abe amaseli aphilayo.Biochemistry 46, 14771-14781 (2007).
I-Kabanov, i-Av, uLavishov, AV & Alakhov, vy Lipid Ukuguqulwa kwamaprotheni nezithuthi zazo ze-membrane. I-Kabanov, i-Av, uLavishov, AV & Alakhov, vy Lipid Ukuguqulwa kwamaprotheni nezithuthi zazo ze-membrane.I-Kabanov Av, uLabashov Av, Alakhov V.YU. Ukuguqulwa kwe-Lipid kwamaprotheni nezithuthi zazo ze-membrane. I-Kabanov, i-Av, uLavishov, AV & Alakhov, Vy 蛋白质的脂质修饰及其膜转运. I-Kabanov, AV, LEVASHOVV, AV & Alakhov, VyI-Kabanov Av, uLevid Av, i-Alakhov, ukuguqulwa kweLipid kwamaprotheni ama-vy kanye nezokuthukwana zawo membrane.ubunjiniyela be-protein. Dec. Searl. 3, 39-42 (1989).
UGao, u-X. UGao, u-X.UGao, X., Mazier, Ad, Byrd, R., Klumperman, J. noHannoosh, RN Fatty accylication akhulisa ukwenziwa kwangaphakathi kwamaselula kanye nokusatshalaliswa kwe-cytosolic kwe-peptop cystine. UGao, X., Mazière, Ad, Beard, R., Klumperman, J. & Hannounh, RN UGao, X., Mazière, Ad, Beard, R., Klumperman, J. & Hannounh, RN.UGao, X., Mazier, Ad, Byrd, R., Klumperman, J. Futhi Hannoosh, RN Fatty Accittern athuthukisa ukusatshalaliswa kwamaselula kanye nokusatshalaliswa kwe-cytoplasmic kwama-ceptines we-cytoplasmic.Iscience 24, 103220 (2021).
I-Baker, em et al. Ukuguqulwa okunempilo-impilo ye-YY3-36 Peptide ye-Direct receptor-medization yangaphakathi. Moore. umuthi. 16, 3665-3677 (2019).
Mäde, V., Bellmann-Weilert, K., Kaiser, A. Meiler, J. & Beck-Sininger, ag isikhundla kanye nobude bamafutha acid athinta kakhulu iphethini ye-Pancreatiple ye-Percreatic. Mäde, V., Bellmann-Weilert, K., Kaiser, A. Meiler, J. & Beck-Sininger, ag isikhundla kanye nobude bamafutha acid athinta kakhulu iphethini ye-Pancreatiple ye-Percreatic.Kwenziwe, W. Bellmann-Weingtert, K., Kaiser, A., Mailer, J. kanye neBeck-Sininger, ag isikhundla kanye nobude bamafutha acid athonya ngokuqinile i-Pancreatic Analog Receptors yomuntu. Mäde, V., Bellmann-Weilert, K., Kaiser, A. Meil ​​Er, J. & Beck-Sininger, AG 脂肪酸的位置和长度强烈影响人胰腺多肽类似物的受体选择性模式. Mäde, V., Bellmann-Weilert, K., Kaiser, A., Meil ​​Er, J. & Beck-Sininger, AGKwenziwe, W. Bellmann-Weilert, K., Kaiser, A., Mailer, J. kanye ne-Beck-lininginger, ag isikhundla kanye nobude bamafutha acidi abathonya ngokuqinile i-Pancreatic Panpeptide Receptors.Himmedchem 9, 2463-2474 (2014).
Aleksopoulou, F. et al. I-Lipid Metabolite PrRP31 iyi-GPR10 esebenza isikhathi eside ye-GPR10 ne-NPFFR2 receptor agonist enamandla okunciphisa isisindo. Isayensi. Bika 12, 1696 (2022). Lesi sifundo seZindlela siqokomisa umehluko phakathi kwamaketanga aseceleni we-diacid.
I-Poulsen, K. et al. Ukuthuthukiswa okunengqondo kobuhlungu obuzinzile be-y2 receptor peptide PYY3-36. umuthi. ithangi lokugcina. 38, 1369-1385 (2021).
Ama-Frie-Frieboes, K. et al. Ukukhonjwa kanye nokuhlongona kwe-vitro nase-vivo analogues ye-melanocortin 4 ekhethiwe (i-MC4-R) i-Alpha-melanocyte-melanocyte-evusa ama-hormone (Alpha-MSH). J. Medicine. Amakhemikhali. 55, 1969-1977 (2012).
URamirez-Andersen, hs et al. Ukuvela kokukhula komuntu okudala okubangelwa yi-hormone eboshelwe ku-albamin engeyona eyokugcina. Bioconjugate. Amakhemikhali. 29, 3129-3143 (2018).
Madsen, k. et al. Ubudlelwane obusebenza-umsebenzi kanye nokuqothulwa kwe-glucagon esebenza isikhathi eside - oku-1 okususelwa ku-perivatives: Ukubaluleka kobude be-fatty acid, ubumbano kanye nevolumu. J. Medicine. Amakhemikhali. 50, 6126-6132 (2007).
I-Weezezorek, B., Spetzler, JC, Kruse, T., Linderetoth, L. & Kofoed, J. Dwelived GLP-1 Derivatives. I-Weezezorek, B., Spetzler, JC, Kruse, T., Linderetoth, L. & Kofoed, J. Dwelived GLP-1 Derivatives. I-Weezezorek, B., Spetzler, JC, KRUSE, T. Linderetoth, L. noFoed, j. дважные I-Weezezorek, B., Spetzler, JC, Kruse, T., Linderereth, L. & Kofeed, J. M. I-Weezezorek, B., Spetzler, JC, KRUSE, T., Limenteth, L. & Kofoed, J. 双酰化 GLP-1 衍生物. I-Weezezorek, B., Spetzler, JC, KRUSE, T., Limenteth, L. & Kofoed, J. 双酰化 GLP-1 衍生物. I-Weezezorek, B., Spetzler, JC, KRUSE, T., Linderetoth, L. & Kofoed, J. диавилезводные pulp-1. I-Weezezorek, B., Spetzler, JC, Kruse, T., Linderereth, L. & Kofeed, J. Diacylived Deperivatives of glp-1.I-US Patent WO2012 / 140117 (2012).
Omncane, P.-YU. Linda. Ama-analog e-glp-1 anamandla, asebenza isikhathi eside aklanyelwe ukulethwa kwe-transdermal ngokusekelwe kwi-miscructure. inqubo. I-National Academy of Science. Isayensi. I-US 113, 4140-4145 (2016).
Ubukhosi, Jeye, Konradsen, G., Eskerod, O. Izihloko. Ubukhosi, Jeye, Konradsen, G., Eskerod, O. Izihloko.Ubukhosi, Jeye, Konradsen, G., Eskerod, O., Wolf, ama-BS ezokuphepha, kanye ne-Pharmacodynamics Study of analog okukodwa kanye nokukhuluphala kwezifundo ezinempilo.版税, Je, konradsen, G., Eskerod, O., Wulff, BS & Hansen, bs 单剂量和多剂量长效 α-msh 类似物在健康超重和肥胖患者中的安全性, 耐受性, 药代动力学和药效学研究科目.版税, Je, konradsen, G., Eskerod, O., Wilff, BS & Hansen, i-BS Umthamo owodwa kanye ne-Music Dosage Effect ende α-MSH 全健康超重和肥胖可以中可以可以而受性, 药代报学学和药效学研究科目.Ubukhosi, Jeye, Konradsen, G., Eskerod, O., Wolf, BS kanye neHansen, ama-POSEs angashadile angenawo ama-Alpha-MSG ezifundweni ezinempilo eziphilayo nezikhulu. Ama-kinetics kanye nama-pharmacodynamics.J. CL. I-Pharmacodynamics. 54, 394-404 (2014).
I-Lau, J., F., KRUSE, T., Linderemeth, L. & Thøgersen, H. Novel Glucagon Alologes. I-Lau, J., F., KRUSE, T., Linderemeth, L. & Thøgersen, H. Novel Glucagon Alologes.I-Lau, J., F., KRUSE, T., iLindendeth, L. kanye ne-Togesen, H. New Glucagon analogues. Lau, J., F., KRUSE, T., Linderemeth, L. & Thøgersen, H. 新型胰高血糖素类似物. I-Lau, J., F., KRUSE, T., Lindermeth, L. & Thøgersen, H.I-Lau, J., F., CRUZ, T., Lindereseth, L. kanye ne-Togesen, H. New Glucagon analogues.I-US Patent WO2011 / 117416 A1 (2011).
Ward, BP et al. Ukuhlukaniswa kwama-peptides kuqinisa izakhiwo ukuthuthukisa umsebenzi webhayoloji. Moore. metabolism. 2, 468-479 (2013). Lo msebenzi ukhombisa indima yamaketanga amakhonkco aseceleni acid ekunqumeni ukuqina kokuhleleka nokubopha ama-peptide izidakamizwa.
Koskun t. et al. I-Ly3298176, inoveli embaxambili ye-gip kanye ne-glp-1 i-ageptor yobukhosi bokwelashwa kwesifo sikashukela sohlobo 2: kusuka ekutholweni kobufakazi bomtholampilo. Moore. metabolism. 18, 3-14 (2018). Leli phepha liveza ukwakheka kwe-Fluty Fatty Acid-Designed GLP-1 / GIP co-agonist yabaphathi kanye namasonto onke eMtholampilo.
Kjeldsen, i-TB et al. Ubunjiniyela be-Molecular ye-Icodec insulin, i-Analog ye-insulin yokuqala yamasonto onke eyake yasebenza ngeviki kubantu. J. Medicine. Amakhemikhali. 64, 8942-850 (2021). Leli phepha liveza ukuthuthukiswa kokuqala kwe-fatty acid kuthathwe i-insulin ukuze kube nesonto ngalinye.
I-Van Witteloostein, SB et al. Ama-NeoglyColipids ama-peptides athatha isikhathi eside: Ukuzihlanganisa ama-analogs we-glucagon-efana ne-peptide 1 nge-albhamuin-factive Properties kanye ne-High in Vivo Polect. Moore. umuthi. 14, 193-205 (2017).
UZorzi, A., Middendorp, SJ, Wilbs, J., uDyley, K. & Heinis, C. Acylated Heptapepturide ahlanganisa ama-albhamu anobudlelwano obukhulu kanye nesicelo njengoba kunikeza ama-peptides amade. UZorzi, A., Middendorp, SJ, Wilbs, J., uDyley, K. & Heinis, C. Acylated Heptapepturide ahlanganisa ama-albhamu anobudlelwano obukhulu kanye nesicelo njengoba kunikeza ama-peptides amade.UZorzi, a. UZorzi, A., Middendorp, SJ, Wilbs, J., DEYYINE, K. & Heinis, C. 酰化七肽以高亲和力结合白蛋白, 并作为标签提供长效肽. UZorzi, A., Middendorp, SJ, Wilbs, J., uDyle, K. & Heinis, C. 鎄化七 Peptide 以高亲和力设计白白约筒, 使用于设计手机长整线等.UZorzi, A., Middendorp, SJ, Wilbs, J.NAT. Khulumisana 8, 16092 (2017).